<DOC>
	<DOCNO>NCT01317134</DOCNO>
	<brief_summary>The objective current study identify evaluate new prognostic non-invasive serological marker patient pulmonary hypertension . The focus L-arginine metabolism clarify influence endothelial function .</brief_summary>
	<brief_title>Endothelial Function Patients With Pulmonary Arterial Hypertension</brief_title>
	<detailed_description>The objective current study identify evaluate new prognostic non-invasive serological marker patient pulmonary hypertension . The focus L-arginine metabolism clarify influence endothelial function . The investigator also want evaluate difference plasma concentration L-arginine/NO metabolite non-invasively assess endothelial function base specific PH-therapy . Furthermore , investigator aim transfer result gain investigator study population in-vitro system order carefully characterize involved signal transduction pathway . Thereby investigator hope identify potentially new therapeutic target PH patient subgroup preferably benefit establish therapeutic option .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<criteria>proven PH ( right heart catheterization , PAP &gt; 25 mmHg , within last 12 month ) age &gt; 18 year Dana Point classification I IV ( subgroup ) declaration consent Pulmonary Hypertension proven right heart catheterization Eisenmenger 's syndrome/reaction PH Dana Point I IV alcohol drug abuse noncompliance due cause ( e.g . severe psychiatric disorder )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Pulmonary Arterial Hypertension</keyword>
	<keyword>Prognostic factor</keyword>
	<keyword>Signal transduction</keyword>
	<keyword>Genetics</keyword>
</DOC>